Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation

Cardiovascular Ultrasound

Volumn 12, Issue 1, 2014, Pages

  Machaalany, Jimmy ^a   Bertrand, Olivier F ^a   O'Connor, Kim ^a   Abdelaal, Eltigani ^a   Voisine, Pierre ^a   Larose, Éric ^a   Charbonneau, Éric ^a   Costerousse, Olivier ^a   Déry, Jean Pierre ^a   Sénéchal, Mario ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Ischemic mitral regurgitation; Mitral valve; Myocardial infarction; Primary percutaneous coronary intervention

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; ISCHEMIC MITRAL REGURGITATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TREATMENT OUTCOME;

EID: 84898539530     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-12-14     Document Type: Article

References (40)

1. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, Warnica JW, Barvik S, Arnold JM, Velazquez EJ, Van de Werf F, Ghali J, McMurray JJ, Kober L, Pfeffer MA, Solomon SD, Eur Heart J 2007 28 326 333 10.1093/eurheartj/ehl464 17251259
2. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL, Circ 2005 111 295 301 10.1161/01.CIR.0000151097.30779.04 (Pubitemid 40165335)
3. Primary percutaneous coronary intervention lowers the incidence of ischemic mitral regurgitation in patients with acute ST-elevated myocardial infarction. Chua S, Hung J, Chung SY, Lin YC, Fu M, Wu CJ, Hang CL, Chai HT, Liu WH, Yang CH, Tsai TH, Chen CJ, Yip HK, Circ J 2010 74 2386 2392 10.1253/circj.CJ-10-0435 20890048
4. Clinical profile and outcome of first acute myocardial infarction with ischemic mitral regurgitation. Chung SY, Lin FC, Chua S, Fu M, Wu CJ, Yip HK, Yeh KH, Chai HT, Hsieh YK, Hang CL, Fang CY, Chen SM, Yang CH, Chen CJ, Lee FY, Chen MC, Chang Gung Med J 2008 31 268 275 18782949 (Pubitemid 351858545)
5. Prognostic significance of mild mitral regurgitation by color doppler echocardiography in acute myocardial infarction. Feinberg MS, Schwammenthal E, Shlizerman L, Porter A, Hod H, Friemark D, Matezky S, Boyko V, Mandelzweig L, Vered Z, Behar S, Sagie A, Am J Cardiol 2000 86 903 907 10.1016/S0002-9149(00) 01119-X 11053696
6. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative doppler assessment. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ, Circ 2001 103 1759 1764 10.1161/01.CIR.103.13. 1759 (Pubitemid 32291413)
7. Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction. Hillis GS, Moller JE, Pellikka PA, Bell MR, Casaclang-Verzosa GC, Oh JK, Am Heart J 2005 150 1268 1275 10.1016/j.ahj.2005.01.020 16338270 (Pubitemid 41773533)
8. Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome. Perez de Isla L, Zamorano J, Quezada M, Almeria C, Rodrigo JL, Serra V, Garcia Rubira JC, Ortiz AF, Macaya C, Eur Heart J 2006 27 2655 2660 10.1093/eurheartj/ehl287 17015403 (Pubitemid 44729864)
9. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Pellizzon GG, Grines CL, Cox DA, Stuckey T, Tcheng JE, Garcia E, Guagliumi G, Turco M, Lansky AJ, Griffin JJ, Cohen DJ, Aymong E, Mehran R, O'Neill WW, Stone GW, J Am Coll Cardiol 2004 43 1368 1374 10.1016/j.jacc.2003. 11.046 15093869 (Pubitemid 38496340)
10. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and ventricular enlargement investigators. Lamas GA, Mitchell GF, Flaker GC, Smith SC Jr, Gersh BJ, Basta L, Moye L, Braunwald E, Pfeffer MA, Circ 1997 96 827 833 10.1161/01.CIR.96.3.827 (Pubitemid 27329616)
11. Current prognosis of ischemic mitral regurgitation. Implications for future management. Hickey MS, Smith LR, Muhlbaier LH, Harrell FE Jr, Reves JG, Hinohara T, Califf RM, Pryor DB, Rankin JS, Circ 1988 78 51 I59
12. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial. Lehmann KG, Francis CK, Sheehan FH, Dodge HT, J Am Coll Cardiol 1993 22 714 719 10.1016/0735-1097(93)90181-Y 8354803 (Pubitemid 23256930)
13. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Lehmann KG, Francis CK, Dodge HT, Ann Intern Med 1992 117 10 17 10.7326/0003-4819-117-1-10 1596042
14. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Tcheng JE, Jackman JD Jr, Nelson CL, Gardner LH, Smith LR, Rankin JS, Califf RM, Stack RS, Ann Intern Med 1992 117 18 24 10.7326/0003-4819-117-1-18 1596043
15. Predictive value of ischemic mitral regurgitation during the acute phase of ST elevation myocardial infarction treated with primary coronary intervention for left ventricular remodeling in long-term follow-up. Wita K, Berger-Kucza A, Filipecki A, Turski M, Bochenek T, Wrobel W, Lelek M, Weglarz P, Elzbieciak M, Trusz-Gluza M, Coron Artery dis 2010 21 325 329 10.1097/MCA.0b013e32833aa6bb 20453641
16. Mitral regurgitation during a myocardial infarction-new predictors and prognostic significance at two years of follow-up. Barra S, Providencia R, Paiva L, Gomes PL, Seca L, Silva J, Nascimento J, Leitao-Marques A, Acute Card Care 2012 14 27 33 10.3109/17482941.2012.655295 22296621
17. Reperfusion therapies reduce ischemic mitral regurgitation following inferoposterior ST-segment elevation myocardial infarction. Poh KK, Lee GK, Lee LC, Chong E, Chia BL, Yeo TC, Coron Artery Dis 2012 23 555 559 10.1097/MCA.0b013e32835aab65 23103758
18. The prognostic role of mitral regurgitation after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Uddin AM, Henry TD, Hodges JS, Haq Z, Pedersen WR, Harris KM, Cathet Cardiovasc Interv 2012 80 779 786 10.1002/ccd.23400
19. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Grossi EA, Crooke GA, DiGiorgi PL, Schwartz CF, Jorde U, Applebaum RM, Ribakove GH, Galloway AC, Grau JB, Colvin SB, Circ 2006 114 573 I576 10.1161/CIRCULATIONAHA.106.647743 (Pubitemid 44706869)
20. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP, Circ 2004 110 588 636 10.1161/01.CIR.0000134791.68010.FA (Pubitemid 39036178)
21. Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty. Corbalan R, Larrain G, Nazzal C, Castro PF, Acevedo M, Dominguez JM, Bellolio F, Krucoff MW, Am J Cardiol 2001 88 342 346 10.1016/S0002-9149(01)01676-9 11545751 (Pubitemid 32823292)
22. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, ESC Committee for Practice Guidelines (CPG), Eur Heart J 2008 29 2388 2442 18799522
23. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman N, J Am Soc Echocardiogr 1989 2 358 367 2698218
24. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ, J Am Soc Echocardiogr 2003 16 777 802 10.1016/S0894-7317(03)00335-3 12835667 (Pubitemid 37391035)
25. Universal definition of myocardial infarction. Thygesen K, Alpert JS, White HD, J A Coll Cardiol 2007 50 2173 2195 10.1016/j.jacc.2007.09.011 (Pubitemid 350123680)
26. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ, Circ 2000 102 1400 1406 10.1161/01.CIR.102.12.1400
27. Reverse ventricular remodeling reduces ischemic mitral regurgitation: echo-guided device application in the beating heart. Hung J, Guerrero JL, Handschumacher MD, Supple G, Sullivan S, Levine RA, Circ 2002 106 2594 2600 10.1161/01.CIR.0000038363.83133.6D (Pubitemid 35345120)
28. Chordal cutting: a new therapeutic approach for ischemic mitral regurgitation. Messas E, Guerrero JL, Handschumacher MD, Conrad C, Chow CM, Sullivan S, Yoganathan AP, Levine RA, Circ 2001 104 1958 1963 10.1161/hc4201.097135 (Pubitemid 32983241)
29. Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography. Watanabe N, Ogasawara Y, Yamaura Y, Kawamoto T, Toyota E, Akasaka T, Yoshida K, J Am Coll Cardiol 2005 45 763 769 10.1016/j.jacc.2004.11.048 15734623 (Pubitemid 40278976)
30. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Aronson D, Goldsher N, Zukermann R, Kapeliovich M, Lessick J, Mutlak D, Dabbah S, Markiewicz W, Beyar R, Hammerman H, Reisner S, Agmon Y, Arch Intern Med 2006 166 2362 2368 10.1001/archinte.166.21.2362 17130390 (Pubitemid 44833362)
31. Significance of doppler-detected mitral regurgitation in acute myocardial infarction. Barzilai B, Gessler C Jr, Perez JE, Schaab C, Jaffe AS, Am J Cardiol 1988 61 220 223 10.1016/0002-9149(88)90919-8 3341197
32. Effect of thrombolytic therapy on the evolution of significant mitral regurgitation in patients with a first inferior myocardial infarction. Leor J, Feinberg MS, Vered Z, Hod H, Kaplinsky E, Goldbourt U, Truman S, Motro M, J Am Coll Cardiol 1993 21 1661 1666 10.1016/0735-1097(93)90384-D 8496534 (Pubitemid 23170442)
33. Pathogenesis of mitral regurgitation in acute myocardial infarction: importance of changes in left ventricular shape and regional function. Van Dantzig JM, Delemarre BJ, Koster RW, Bot H, Visser CA, Am Heart J 1996 131 865 871 10.1016/S0002-8703(96)90166-0 8615303 (Pubitemid 26135747)
34. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Keeley EC, Boura JA, Grines CL, Lancet 2003 361 13 20 10.1016/S0140-6736(03)12113-7 12517460 (Pubitemid 36050955)
35. Female gender: an independent factor in ST-elevation myocardial infarction. Trigo J, Mimoso J, Gago P, Marques N, Faria R, Santos W, Candeias R, Pereira S, Marques V, Brandao V, Camacho A, de Jesus I, Gomes V, Rev Port Cardiol 2010 29 1383 1394 21179979
36. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Vakili BA, Kaplan RC, Brown DL, Circ 2001 104 3034 3038 10.1161/hc5001.101060 (Pubitemid 34014053)
37. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction. Wijnbergen I, Tijssen J, van't Veer M, Michels R, Pijls NH, Cathet Cardiovasc Interv 2013 82 379 384 10.1002/ccd.24800
38. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, et al. Circ 2006 114 84 e231 10.1161/CIRCULATIONAHA.106.176857 (Pubitemid 44268973)
39. Guidelines on the management of valvular heart disease (version 2012). Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M, Eur Heart J 2012 33 2451 2496 22922415
40. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ, Am J Cardiol 1999 83 897 902 10.1016/S0002-9149(98)01064-9 10190406 (Pubitemid 29143128)